Acute Aortic Dissection
.
.
.
🎦Here’s a nice series of echo images showing a Sanford Type A (Debakey type 2) aortic dissection involving the ascending aorta, root, arch, and descending. You can clearly see the intimal flap which will have independent motion from the rest of the…

Srihari S. Naidu, MD FTC SCAI Now American College of Cardiology Heart Rhythm Society MSSNYPAC AMA The ruling details that the FTC has oversight over non-profits as well. Expect this to be challenged in court.

Everyone. I’m glad FTC came through tentatively. But we’ve known this doesn’t include nonprofits which are the MAJORITY of hospitals. This is why we’ve been fighting within the state system. It does show consensus is on our side though! Please spread so there’s no confusion.

#ReverseWiringTechnique ↩️through a #DualLumenMC

#ShorteningAGuide for distal reach when a specific 90 cm #CoronaryGuide is unavailable

PCRonline 🫀 SCAI Now MyJSCAI
Andrew M. Goldsweig, MD, MS Mamas A. Mamas Jay Bagai Jay Giri Eric Secemsky MD MSc Sahil A. Parikh, MD Michael Megaly Antonious Attallah, MD, FACC, FSCAI…

•Carotid Artery Stenosis•
.
.
.
We currently have three main ways to treat carotid disease.
1️⃣ Medical Management
2️⃣ Carotid endarterectomy
3️⃣ Carotid Stenting .
.
🔪Carotid Endarterectomy
.
.
☑️Symptomatic patients with 70-99% stenosis - Clear benefit was found in the…

A Little trick to save the radial access for an arterial line after #PCI , thanks to Gianluca Campo for the idea!

The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.

Read more: bit.ly/3xuHWrl

#ACC24

I can’t remember a conference with so many positive studies for interventional cardiology

#ACC2024

Second Prospective Randomized Control Trial Demonstrating the Benefit of Peripheral IVUS! 237 patients with fempop disease randomized to IVUS-guided DCB treatment vs angio-guided DCB treatment. 14% improvement in patency at 1 year, aligned with results from prior 150 person…

Thrilled to present at #ACC24 for the third time in a row🫀!!
Thanks to Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI & Chadi Alraies, MD FACC FSCAI for all the support and guidance! American College of Cardiology #Cardiology

Check out our abstract in JACC Journals! jacc.org/doi/abs/10.101…

Ultrasound-guided #radialfirst access had

⬆️first pass success (76.92% vs. 49.45%)

⬇️no of attempts (1.46 ± 1 vs. 1.99 ± 1.46)

⬇️(93.62 ± 44.04 vs 120.44 ± 67.1, p 0.002) compared w palpation guidance

Palpation had ⬆️spasm

🔗onlinelibrary.wiley.com/doi/10.1002/cc…

Bryan Rene Toledano, MD, FESC #CardioX

Among patients with obesity-related heart failure with preserved ejection fraction & type 2 diabetes, semaglutide produced greater reductions in symptoms, physical limitations & body weight than placebo at 1 year. Full STEP-HFpEF DM trial results: nej.md/3TPKpUC

#ACC24

Would you EVER do an axfem/axbifem for claudication? Vascular SVS CSVS #AortaEd

This matters!!!! Joe Biden CMSGov U.S. FDA Dr. Robert M. Califf
Physicians are exhausted!!

Really cool idea by American College of Cardiology and industry to provide free Lp(a) screening for everyone at #ACC24 booth 21

Already know my south Asian genes are about to 🤕🔨

#ACC24
VICTORION-INITIATE Trial
🫀Pt with ASCVD, Max tol statin +LDL>70 randomized to #inclisiran 1st strategy🆚 UC
🫀Inclisiran 1st: more effective than UC practices at absolute LDL-C ⤵️ & achieving guideline-recommended LDL
🫀UC: few patients got to target LDL goal😢
🫀<1/3 💃🏻

Turn those abstracts into manuscripts

Don’t let them end up here … #ACC24

Submit them to ⁦JACC Journals⁩

SMART trial comparing SEV and BEV - impressive findings. No difference in mortality but marked difference in valve dysfunction. More women studied. Better hemodynamics at 12 months could mean better valve durability in small annuli over time American College of Cardiology #ACC2024

Presented today at #ACC24 :

In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t